Sale!

Cancer Targeted Gene Panel Lung with PDL1 DAKO Test

Original price was: $1,126.Current price is: $876.

-22%

The Cancer Targeted Gene Panel Lung with PDL1 DAKO Test is a comprehensive molecular diagnostic assessment designed specifically for lung cancer patients. This advanced test analyzes multiple genetic markers including ALK1, ROS1, MET amplification, MET mutation, KRAS, BRAF, ERBB2, EGFR, and PDL-1 using Dako methodology. It provides crucial information for targeted therapy selection, immunotherapy response prediction, and personalized treatment planning. The test utilizes IHC, FISH, and NGS technologies to deliver precise genetic profiling. Available for $876 USD, this panel helps oncologists make informed decisions about treatment strategies based on individual genetic characteristics. Results are typically available by the 15th or 30th of the same month when samples are submitted by the 1st or 16th.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Cancer Targeted Gene Panel Lung with PDL1 DAKO Test

Comprehensive Genetic Analysis for Lung Cancer Treatment

The Cancer Targeted Gene Panel Lung with PDL1 DAKO Test represents a cutting-edge approach to personalized cancer care. This comprehensive molecular diagnostic panel is specifically designed for lung cancer patients, providing oncologists with critical genetic information to guide targeted therapy decisions and immunotherapy treatment planning.

What This Advanced Test Measures

Our sophisticated panel analyzes multiple crucial genetic markers and biomarkers essential for lung cancer management:

  • ALK1 Rearrangement – Identifies patients eligible for ALK inhibitors
  • ROS1 Fusion – Detects ROS1 gene rearrangements for targeted therapy
  • MET Amplification & Mutations – Assesses MET pathway alterations
  • KRAS Mutations – Evaluates RAS pathway activation
  • BRAF Mutations – Identifies BRAF V600E and other mutations
  • ERBB2 (HER2) Alterations – Detects HER2 amplification and mutations
  • EGFR Mutations – Screens for EGFR tyrosine kinase domain mutations
  • PDL-1 Expression (Dako) – Measures PD-L1 protein levels for immunotherapy response prediction

Who Should Consider This Test

This comprehensive genetic panel is recommended for:

  • Newly diagnosed non-small cell lung cancer (NSCLC) patients
  • Patients with advanced or metastatic lung cancer
  • Individuals who have failed initial chemotherapy treatments
  • Patients being considered for targeted therapy or immunotherapy
  • Those with recurrent lung cancer requiring new treatment options
  • Patients with family history of lung cancer or genetic predisposition

Key Benefits of Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Personalized Treatment Planning – Tailor therapies based on individual genetic profile
  • Targeted Therapy Selection – Identify patients who will benefit from specific targeted drugs
  • Immunotherapy Response Prediction – Assess likelihood of response to checkpoint inhibitors
  • Avoid Unnecessary Treatments – Prevent ineffective therapies and associated side effects
  • Improved Survival Outcomes – Access to more effective, genetically-matched treatments
  • Comprehensive Genetic Profile – Single test covering multiple relevant biomarkers

Understanding Your Test Results

Your results will provide detailed information about:

  • Genetic Mutations Present – Specific alterations detected in your cancer cells
  • Targeted Therapy Options – Medications that may be effective based on your genetic profile
  • PD-L1 Expression Levels – Indication of potential response to immunotherapy
  • Treatment Recommendations – Evidence-based suggestions for your oncologist
  • Clinical Trial Eligibility – Information about potential clinical trial opportunities

Your oncologist will review these results with you and develop a personalized treatment plan based on the genetic characteristics of your cancer.

Test Pricing Information

Test Name Discount Price Regular Price
Cancer Targeted Gene Panel Lung with PDL1 DAKO Test $876 USD $1126 USD

Sample Requirements and Processing

Sample Type: Formalin fixed paraffin embedded tissue block

Shipping Instructions: Ship at room temperature with proper documentation

Required Documentation:

  • Copy of Histopathology report
  • Site of biopsy information
  • Complete clinical history
  • Duly filled NGS Test Requisition Form (Form 40)

Turnaround Time

We offer efficient processing with results available by:

  • Samples submitted by 1st of month: Reports available by 15th of same month
  • Samples submitted by 16th of month: Reports available by 30th of same month

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible, high-quality genetic testing for lung cancer patients nationwide.

Book Your Test Today

Take the first step toward personalized lung cancer treatment. Our genetic testing provides the critical information needed to make informed treatment decisions. Contact us today to schedule your Cancer Targeted Gene Panel Lung with PDL1 DAKO Test.

Call or WhatsApp: +1(267) 388-9828

Our experienced genetic counselors and oncology specialists are available to answer your questions and help you understand how this comprehensive genetic analysis can benefit your treatment journey.